Drug-company sponsorship and the Declaration of Helsinki.
Publication
, Journal Article
Brown, DL
Published in: Lancet
May 5, 2001
Duke Scholars
Published In
Lancet
DOI
ISSN
0140-6736
Publication Date
May 5, 2001
Volume
357
Issue
9266
Start / End Page
1448 / 1449
Location
England
Related Subject Headings
- Research Support as Topic
- Randomized Controlled Trials as Topic
- Platelet Aggregation Inhibitors
- Placebos
- Peptides
- Patient Selection
- Humans
- Helsinki Declaration
- General & Internal Medicine
- Eptifibatide
Citation
APA
Chicago
ICMJE
MLA
NLM
Brown, D. L. (2001). Drug-company sponsorship and the Declaration of Helsinki. Lancet, 357(9266), 1448–1449. https://doi.org/10.1016/S0140-6736(00)04603-1
Brown, D. L. “Drug-company sponsorship and the Declaration of Helsinki.” Lancet 357, no. 9266 (May 5, 2001): 1448–49. https://doi.org/10.1016/S0140-6736(00)04603-1.
Brown DL. Drug-company sponsorship and the Declaration of Helsinki. Lancet. 2001 May 5;357(9266):1448–9.
Brown, D. L. “Drug-company sponsorship and the Declaration of Helsinki.” Lancet, vol. 357, no. 9266, May 2001, pp. 1448–49. Pubmed, doi:10.1016/S0140-6736(00)04603-1.
Brown DL. Drug-company sponsorship and the Declaration of Helsinki. Lancet. 2001 May 5;357(9266):1448–1449.
Published In
Lancet
DOI
ISSN
0140-6736
Publication Date
May 5, 2001
Volume
357
Issue
9266
Start / End Page
1448 / 1449
Location
England
Related Subject Headings
- Research Support as Topic
- Randomized Controlled Trials as Topic
- Platelet Aggregation Inhibitors
- Placebos
- Peptides
- Patient Selection
- Humans
- Helsinki Declaration
- General & Internal Medicine
- Eptifibatide